Precision BioLogic has some exciting acquisition news that will position them for further growth:
From: Precision Biologic
Date: Feb. 28, 2024
Procuritas Partners with Precision BioLogic
Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to healthcare across the globe.